Group Critical Illness - Small victories

Usually, when a product manages to increase its number of lives covered and the premiums it brings in, we think this is a good thing, don't we? Yet, despite group critical illness (CI) doing this, the product can still be said to be underperforming. On one hand, there are the statistics and research from the Association of British Insurers (ABI), and analysis published by Swiss Re in its Group Watch 2009 which show that the product's performance has been improving rapidly in comparison to earlier years. That is in relation to itself. In comparison with group life and income protection (...